STOCKHOLM, Sweden--(BUSINESS WIRE)--SALES Full-year 2008 Net sales for 2008 rose 31% to SEK 10,675 million (8,145). Exchange rate effects for comparable units had a positive SEK 293 million impact on sales compared to the previous year. The acquired Valeant and Recip operations contributed SEK 389 million and SEK 747 million (35) respectively, and sales in the US accounted for SEK 2,244 million. Sales of the products recently acquired from Roche amounted to SEK 121 million. Sales of the most important products during the whole of 2008 were:
